CIK 0001730430
- Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981795578
- Phone
- +1 781-431-9100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy 10% owner bought 843,352 shares at an average $18.97 ($15,996,834)
- 4 Open-market buy 10% owner bought 69,444 shares at $18.00 ($1,249,992)
- 4 Open-market buy Director bought 3,000,000 shares at $18.00 ($54,000,000)
- 4 Conversion Chairman & CEO acquired 135,889 shares (conversion)
- 4 Conversion Chief Legal Officer acquired 6,392 shares (conversion)
- 4 Conversion Director acquired 71,967 shares (conversion)
- 4 Conversion 10% owner acquired 6,392 shares (conversion)
- 4 Conversion President & COO acquired 6,392 shares (conversion)
- 4 Conversion Exec VP & CFO acquired 6,392 shares (conversion)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 19 of 20 · 386 filings